Cooperative Agreement U48DP006844
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$600K
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.283
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
The federal Cooperative Agreement award U48DP006877, "MANAGING EPILEPSY WELL (MEW) NETWORK", is provided by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The $700,000 award, effective September 30, 2024 through September 29, 2027, supports research, surveillance, and technical assistance to state and local health authorities, academic institutions, and global health organizations focused on...
The University of Arizona was awarded a $600,000 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to conduct an economic analysis of an evidence-based epilepsy self-management intervention called MINDSET in community and healthcare settings. The project will run from September 30, 2024 to September 29, 2027. The University of Texas Health Science Center at Houston was awarded a sub-grant under...
This federal Cooperative Agreement award, titled "ARISE COORDINATING AND COLLABORATING CENTERS FOR THE STUDY OF VACCINE HESITANCY AND UPTAKE (CDC SIP 12)", was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The $799,904 award, effective from September 30, 2024 to September 29, 2029, will support New York University in conducting research to enhance public health agencies'...
This Cooperative Agreement award for $900,000.00 is funded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, with a performance period from September 1, 2024 to September 1, 2028, supports the "Surveillance of Muscular Dystrophies Component A" project conducted by the awardee, Health Research, Inc., through its Center for Environmental Health Division. The project involves research,...
This $600,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 Investigations and Technical Assistance program supports the documentation of outcomes associated with persistent tic disorders, including Tourette Syndrome, in children, adolescents, and young adults through surveillance. The award was made to the University of South Florida and will be performed in Florida from September 30, 2024 through September 29, 2029. The project aims...
This federal Cooperative Agreement award, identified as U48DP006848, was granted by the Centers for Disease Control and Prevention (CDC) under the Centers for Research and Demonstration for Health Promotion and Disease Prevention (CFDA 93.135) program. The $299,996.00 award was granted to New York University (NYU) on September 30, 2024, with a performance period running through September 29, 2029. Under this Cooperative Agreement, NYU will conduct applied public health research to develop, test,...
This federal Cooperative Agreement award, titled "CORE - NYU-CUNY PREVENTION RESEARCH CENTER" (Award ID: U48DP006778), was granted by the National Center for Chronic Disease Prevention and Health Promotion, a division of the Centers for Disease Control and Prevention (CDC). The award falls under the CDC's Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) and provides $2,000,000.00 in funding to New York University (NYU) from September 30, 2024 to September...
This Cooperative Agreement award, totaling $416,804.00, was provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to the City of New York, Department of Health and Mental Hygiene (Health Dept). The award aims to strengthen vaccine-preventable disease prevention and response efforts in New York City, with a project period from July 1, 2025 to June 30, 2030. The Health Dept, as the primary awardee, will utilize this...
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $3,940,692.87 to conduct a Phase 3 clinical trial of an e-health behavioral intervention called "Epilepsy Journey" to improve executive functioning in adolescents with epilepsy. The goal is to determine the efficacy of the intervention's self-guided learning...
This Cooperative Agreement award, titled "MODELING HIV, VIRAL HEPATITIS, STI, AND TB TO IMPROVE PUBLIC HEALTH - CAMP 3.0: THE COALITION FOR APPLIED MODELING FOR PREVENTION", is funded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The $2,745,600 award will support Emory University and its sub-awardees, the University of Washington, Oregon Health & Science University, and Johns Hopkins...